Latest Strategy Changes News

Pioneer Minerals has completed a critical airborne VTEM survey over its Springfield Tungsten-Gold-Gallium Project in Idaho, setting the stage for maiden drilling after integrating multiple datasets and securing key approvals.

Manhattan Gold Corporation has wrapped up a high-resolution LiDAR survey and maiden channel sampling at its Hook Lake Project, Nunavut, while drilling has commenced at the Jaws target to validate historic gold mineralisation.

Bellevue Gold delivered a strong June 2026 quarter, surpassing production targets and slashing hedge commitments, boosting cash reserves and positioning for growth in FY27.

Venari Metals has agreed to sell its Georgina Basin IOCG Project in the Northern Territory to UK-listed Alien Minerals, marking a strategic shift towards its lithium and critical metals operations in Nevada. The deal includes cash, equity, and a technical services agreement, but will trigger a significant accounting loss.

Booster Wines Limited has proposed exiting its Hawke’s Bay vineyard and winery leases from the Private Land and Property Portfolio, offering a discounted convertible debt payment amid falling grape demand.

A significant shareholder bloc opposing Floorscape's acquisition has forced Bremworth to abandon its Scheme of Arrangement, leaving the flooring manufacturer to pursue standalone growth amid tough market conditions.

Promisia Healthcare’s aged care occupancy climbed to a record 96% in June 2026, underpinning its FY27 earnings growth guidance. Aldwins House led the turnaround, while solar initiatives and wellness programs roll out across sites.

The a2 Milk Company faced significant supply chain disruptions in its China infant formula segment during late FY26, causing a 14% sales decline in that category. Despite this, overall revenue rose 12% on FY25, supported by strong performances in other product lines and improved margins.

PainChek announces the immediate departure of CEO Philip Daffas, with COO Andy Hoggan stepping in as interim leader amid a strategic pivot to boost US market growth following FDA clearance.

Accent Resources NL has struck a deal to sell its Norseman Gold Project for up to A$4 million in cash, while keeping iron ore and platinum group element rights and securing a royalty stream on future mineral production.

Nexalis Therapeutics has ended funding negotiations with Point8 Capital after failing to secure a formal agreement, while successfully completing its IRX-616a Phase 1 trial with no serious adverse events. The company is reassessing clinical priorities amid funding uncertainty.

Nelson Resources appoints Nicholas Ong to its board while progressing underground drilling at its Gold Point project in Nevada, with assay results pending and a second drilling phase imminent.